Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?
- PMID: 38651464
- PMCID: PMC11036198
- DOI: 10.3390/pediatric16020025
Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?
Abstract
The term "non-alcoholic fatty liver disease" (NAFLD) has been, for a long time, used to describe the spectrum of liver lesions encompassing steatosis, steatohepatitis (NASH), and steatotic cirrhosis [...].
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Nascimbeni F., Ballestri S., Machado M.V., Mantovani A., Cortez-Pinto H., Targher G., Lonardo A. Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Rev. Gastroenterol. Hepatol. 2018;12:351–367. doi: 10.1080/17474124.2018.1415756. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources